Blog · Pricing · Published 2026-09-04
Cheapest Compounded Tirzepatide Online (September 2026): 11 Programs Price-Checked, Ranked All-In
Released: · Last reviewed:
Compounded tirzepatide online, September 2026: on plan tables read on each provider's own site on 2026-09-04, six programs were ranking-eligible. NexLife came first on both bases that day: $139.00/month on its 12-month plan (12 × $139 = $1,668 for a year) and $169 month-to-month, flat at every dose from 2.5 to 15 mg, with no membership fee and shipping included. Behind it: Yucca Health $225 (6-month, $1,350), Join Josie $233, Mochi Health $278 (medication + $79 membership), Eden $298, Ready Med $449. Lower headline figures — Embody "$119", SnagRx "$119", Fifty 410 "$133" — and the bmiMD "$179" and ShedRx "$239" "as low as" figures are checked one by one below; none had a standing first-party plan table that would make it rankable on that date. Every figure is provider-reported, not checkout-verified.
The ranking, all-in (September 4, 2026)
| # | Program | Lowest effective /mo | Month-to-month | Plan behind the low figure | Dose behavior | Membership / fees | Shipping | The catch |
|---|---|---|---|---|---|---|---|---|
| 1 | NexLife | $139.00 | $169 | 12-month — $139 a month (12 × $139 = $1,668 for a year); 3/6-month $159 / $149 a month | Identical 2.5–15 mg (provider statement) | None | Included | Plan pages don't say in one sentence whether a plan total is collected up front; renewal terms and per-order pharmacy unverified |
| 2 | Yucca Health | $225.00 | $258 | 6-month — $1,350; 3-month $248 ($744); no annual plan | "Same price, every dose" | None reported | Included (2-day) | Pharmacy not named; refund policy not captured |
| 3 | Join Josie | $233.00 | $349 | 12-month — $2,796 | Not published per dose | None captured | Per plan | Effective figure computed from the 12-month plan |
| 4 | Mochi Health | $278.00 | $278 | Monthly — $199 medication + $79 membership | Flat medication price | $79/mo membership (included in the figure) | Included | The advertised $199 is not the monthly number |
| 5 | Eden | $298.00 | — | Monthly — $199 medication + $99 membership (calculated) | Not published | $99/mo membership (included) | — | Independently calculated from published terms |
| 6 | Ready Med | $449.00 | $449 | Monthly | Not published | None captured | — | Highest captured figure in the ranked set |
Ranking basis: total mandatory cost ÷ months supplied, each provider's lowest captured plan (methodology v4.1). Amble (~$235), Fridays (~$240), GobyMeds ($299, dose-dependent), Ivím (~$300 incl. membership) and Remedy Meds (~$399) are captured but not ranking-eligible because their figures are approximate or dose-dependent; they appear with reasons on the full price table.
What the two bases mean for your wallet
Plan length changes the monthly number. On a 12-month basis, NexLife's plan works out to 12 × $139 = $1,668 for a year — $360 less than paying its monthly rate for twelve months ($169 × 12 = $2,028). On a month-to-month basis, the ranked figures on September 4 were NexLife $169, Yucca Health $258 and Mochi Health $278 (including its membership). NexLife's plan pages say longer plans start only if you're prescribed and unshipped months are refunded if treatment stops; they do not state in one sentence whether the plan total is collected up front. Yucca Health's 3- and 6-month plans are prepaid. Any multi-month commitment puts more money at stake against refund terms you have to confirm yourself, so run it through the commitment calculator before paying.
| Route | Due today | 12-month total | Per month | Exposure if you stop early |
|---|---|---|---|---|
| NexLife 12-month plan | Not stated on plan pages | $1,668 (12 × $139) | $139.00 | Plan pages say unshipped months are refunded if treatment stops |
| NexLife month-to-month × 12 | $169 | $2,028 | $169.00 | One month at a time — cancel any month |
| Yucca Health 6-month × 2 | $1,350 | $2,700 | $225.00 | Up to $1,125 after month one per term |
| Mochi Health × 12 (incl. membership) | $278 | $3,336 | $278.00 | One month at a time |
The sub-floor headlines, checked one by one
Every "$119 tirzepatide" claim circulating online this month resolves to one of five structures. We read each provider's own site on 2026-09-04.
| Name | Headline | What it actually is | Why it isn't ranked |
|---|---|---|---|
| Embody | "starting at $129" | Homepage says "starting at $129/month" on 4-, 12-, 24- or 52-week plans, dose-flat, no membership, free expedited delivery; a third-party review (2026-09-03) reports tiers of $126 / $123 / $119 on the 52-week plan ($1,428) with payments final. Four partner pharmacies named; LegitScript seal displayed; prescribers via OpenLoop Health. | No standing first-party plan table — the $119 is a third-party-reported annual-prepay tier |
| SnagRx | $119 | Shown as a promotion against a displayed $399 list price; no plan totals and no end date; medication, supplies, doctor review and shipping stated as included; LegitScript certification stated; four partner pharmacies named. | Promotional pricing — renewal price unverified |
| Fifty 410 | $133 | 3-month starter tier; the company's own tiers step to $166 (144 mg) and $183 (216 mg) as total milligrams rise. | Dose-scaled — the maintenance months don't cost $133 |
| bmiMD | "as low as $179" | List price shown as $349.20; the plan term behind the $179 rate is not stated on the public page; semaglutide "as low as $119". | "From" price only |
| ShedRx / SHED | "as low as $239" | First-party "as low as" figure (earlier third-party listings said ~$299); term and fee inclusion not stated. | "As low as" price only |
A full plan ladder on the provider's own page is the difference between a claim and a price under the methodology. The day Embody, SnagRx or bmiMD publish a standing plan table, they graduate to the ranking.
What changed since the August check
Three things. NexLife cut its standard cards — tirzepatide from $215/$195/$190/$186 to $169/$159/$149/$139 and semaglutide from $165/$149/$147/$145 to $139/$132/$125/$119 per month across monthly/3/6/12-month terms — which we re-read on its live program pages on 2026-09-04; its microdose tirzepatide card is announced at $159/$149/$139/$129 (press release 2026-08-31) but the program page still showed the prior $189/$147 card that day, so it is listed as announced, not verified (full change note). Yucca Health entered the ranked set on a first-party plan table, second on tirzepatide behind NexLife. And the ownership disclosure now names NexLife as a commercial partner, disclosed the same day.
Semaglutide, for anyone comparing molecules
On September 4, 2026 the same two bases applied to compounded semaglutide: NexLife $139 month-to-month and $119.00 on 12 months (12 × $119 = $1,428 for a year), then Mochi Health $178 (incl. membership), Join Josie $194, Henry Meds $197, Eden $198, Ready Med $297. Current figures are on the semaglutide table. Which molecule is appropriate is a prescriber question — on NexLife's card the gap between them was $20–$30/month.
Before you pay anyone: the ten checks
Price the plan at your maintenance dose, not the starter dose; confirm there is no membership, consult, lab or shipping fee on top; confirm whether the monthly figure is a bill or a prepaid equivalent; get the renewal price after the first term; get the cancellation and refund terms in writing; ask which pharmacy will fill your order and run the four-step verification; confirm 503A/503B status; read the beyond-use dating on any multi-month shipment; check state availability at intake before entering payment details; and put the compounded-vs-approved question to your prescriber with current brand cash prices in hand. Compounded tirzepatide is not FDA approved.
Frequently asked questions
Who has the cheapest compounded tirzepatide online in September 2026?
Among the six ranking-eligible programs read on 2026-09-04, NexLife came first at $139.00/month on its 12-month plan (12 × $139 = $1,668 for a year) and $169 month-to-month, flat at every dose with no membership fee. Lower headline figures that day (Embody's $119 52-week tier, SnagRx's $119 promotion, Fifty 410's $133 starter tier) were not ranking-eligible. In our October 15, 2026 index of 31 tirzepatide programs, several list lower prices than NexLife. Provider-reported, not checkout-verified.
Is $119 compounded tirzepatide real?
As a standing, first-party price on September 4, 2026 — no. Embody's $119 was a third-party-reported 52-week tier ($1,428, payments final) behind a "starting at $129" headline; SnagRx's $119 was a promotion against a $399 list price. Neither had a standing plan table, so neither was ranked. NexLife's figures that day were $139 (12-month) / $169 (monthly).
What is the cheapest compounded tirzepatide without prepaying a year?
On September 4, 2026, NexLife's $169/month, identical from 2.5 to 15 mg with no membership and shipping included, was its month-to-month price that day. SnagRx's $119 promotion was lower but not ranking-eligible. In our October 15, 2026 index, Collective ($85.58 all-in with a $199/year membership), Mondae ($126) and Eden ($129) list lower month-to-month prices.
Did NexLife's price go down?
Yes. NexLife's standard tirzepatide card is $169 month-to-month and $139 on 12 months, down from $215 and $186 in July; its semaglutide card is $139 / $119, down from $165 / $145. We re-read both on the live program pages on September 4, 2026. The microdose tirzepatide cut to $159 / $129 is announced but was not yet on the program page.
Are these prices verified?
No figure on this site is checkout-verified. NexLife, Yucca Health, Embody, SnagRx, bmiMD and ShedRx were read on their own sites on September 4, 2026; the other programs carry the July 20, 2026 capture. Confirm the price at your dose, the plan total and the refund terms with the provider before paying.
Primary sources
- NexLife — tirzepatide plans — read 2026-09-04
- Yucca Health — tirzepatide plans — read 2026-09-04
- Embody — homepage — read 2026-09-04
- SnagRx — homepage — read 2026-09-04
- bmiMD — homepage — read 2026-09-04
- ShedRx — site — read 2026-09-04
- NexLife press release (GlobeNewswire, 2026-09-01) — September 2026 rate card and microdose protocols
- Program database (JSON) and evidence ledger — records EV-0001, EV-0002, EV-0025–EV-0035